Invibio Partnership - The strategic partnership combines CES’ expertise in R&D and business development with Invibio’ s market leading expertise in biomaterials and PEEK.
Together the two organizations were able to co-innovate to develop the first HA (hydroxyapatite) enhanced lumbar peek interbodies in the United States, the EVOS-HA.
The integration of two proven Invibio biomaterials combined with cutting edge designs and the largest range of footprints in the market is a game changer. The strategic partnership with Invibio made it possible, and was key to obtaining FDA clearance.
Click here to download the EVOS-HA brochure.